Cite

HARVARD Citation

    Shao, Y. et al. (2022). Proteomics profiling of colorectal cancer progression identifies PLOD2 as a potential therapeutic target. Cancer communications. 42 (2), pp. 164-169. [Online]. 
  
Back to record